{"id":"NCT01698554","sponsor":"Allergan","briefTitle":"Bimatoprost in the Treatment of Eyelash Hypotrichosis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11","primaryCompletion":"2014-02","completion":"2014-03","firstPosted":"2012-10-03","resultsPosted":"2015-02-10","lastUpdate":"2015-02-10"},"enrollment":464,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Idiopathic Eyelash Hypotrichosis"],"interventions":[{"type":"DRUG","name":"bimatoprost formulation A solution","otherNames":[]},{"type":"DRUG","name":"bimatoprost solution 0.03 %","otherNames":["LATISSE®"]},{"type":"DRUG","name":"vehicle of bimatoprost formulation A solution","otherNames":[]},{"type":"DRUG","name":"vehicle of bimatoprost solution 0.03 %","otherNames":[]}],"arms":[{"label":"bimatoprost formulation A solution","type":"EXPERIMENTAL"},{"label":"bimatoprost solution 0.03 %","type":"ACTIVE_COMPARATOR"},{"label":"vehicle of bimatoprost formulation A solution","type":"PLACEBO_COMPARATOR"},{"label":"vehicle of bimatoprost solution 0.03 %","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of bimatoprost solution formulation A compared with bimatoprost solution 0.03% (LATISSE®) and vehicle in the treatment of eyelash hypotrichosis (inadequate eyelashes).","primaryOutcome":{"measure":"Percentage of Participants With at Least a 1-Grade Increase (Improvement) From Baseline in the Investigator's Assessment of Overall Eyelash Prominence (GEA)","timeFrame":"Baseline, Month 4","effectByArm":[{"arm":"Bimatoprost Formulation A Solution","deltaMin":82.4,"sd":null},{"arm":"Bimatoprost Solution 0.03 %","deltaMin":83.4,"sd":null},{"arm":"Vehicle of Bimatoprost Formulation A Solution","deltaMin":24,"sd":null},{"arm":"Vehicle of Bimatoprost Solution 0.03 %","deltaMin":20.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":8},"locations":{"siteCount":4,"countries":["United States","Russia","Sweden","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":153},"commonTop":["Intraocular pressure decreased"]}}